Background: The SELMA device features a nontraumatic system for suction of the secretions built up above the body/cuff of the LMA, designed by clinicians to improve patient safety during anaesthesia for airway surgery. SELMA has a suction shield to the oropharyngeal surface of the LMA, supported by struts which allows capture of pooled secretions and suction away from the upper airway. AIM: to confirm that the flexible style SELMA product is safe and clears secretions/blood with intermittent suction application (up to 200mmHg) while performing equivalently in function to the existing flexible LMA base product based on the experience of the clinicians utilising the airway device. METHODOLOGY Study design: observational, open label, non-randomised prospective study on a single cohort of thirty voluntary adult patients having nasal or oral surgery at two private hospitals in Toowoomba, Queensland. Primary Endpoint - safety of the SELMA device with equivalent baseline function to standard LMAs (insertion, ventilation and removal) Secondary Endpoints: Application of standard airway suction will achieve clearance of secretions from the oropharyngeal surface of the SELMA. Patient discomfort including sore throat and postoperative nausea and vomiting Whether droplet/splash exposure to staff was reduced during the removal of the SELMA Any adverse events that arose during the case, whether related to airway device or not. Clinician satisfaction with the device Statistical Analysis – qualitative data collection looking at device safety and function - descriptive statistics and binomial analysis RESULTS – pending, currently awaiting final ethics approval by St Vincent’s Hospital Australia HREC. CONCLUSION – pending